PORTAGE BIOTECH INC ALP
SHS NEW · Common Stock · CUSIP G7185A136
- SectorFinancials
- IndustryFinance Services
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $0.32.
Trends to Q1 2026
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2024 | 15 |
| Q4 2024 | 15 |
| Q1 2025 | 16 |
| Q2 2025 | 15 |
| Q3 2025 | 12 |
| Q4 2025 | 13 |
| Q1 2026 | 22 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2024 | 5 | 4 |
| Q1 2025 | 4 | 5 |
| Q2 2025 | 4 | 5 |
| Q3 2025 | 3 | 7 |
| Q4 2025 | 3 | 4 |
| Q1 2026 | 12 | 2 |
Biggest buyers
| SABBY MANAGEMENT, LLC | New | +2.1m |
| Shay Capital LLC | New | +612.3k |
| FNY Investment Advisers, LLC | New | +178.7k |
| One68 Global Capital, LLC | New | +112.0k |
| PRELUDE CAPITAL MANAGEMENT, LLC | New | +85.0k |
| Warberg Asset Management LLC | New | +42.1k |
| XTX Topco Ltd | New | +23.2k |
| TWO SIGMA SECURITIES, LLC | New | +21.3k |
| NORDEN GROUP LLC | New | +12.5k |
| UBS Group AG | Added | +5.4k |
Biggest sellers
| OSAIC HOLDINGS, INC. | Reduced | -50 |
| SBI Securities Co., Ltd. | Sold out | -2 |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
Bailey Gregory
13D · may seek influence
filed 2025-01-31
Stated purposeThe reporting person acquired 402,439 ordinary shares, in an exempt private offering, at $4.10 per share, by agreement dated January 23, 2025, as an investment, to provide operating capital to the issuer, Portage Biotech Inc. The securities currently held and that were acquired as reported herein, are being held for investment purposes. The Reporting Person intends to review his investment in the Issuer on a continuing basis and will routinely monitor a wide variety of investment considerations, including, without limitation, current and anticipated future trading prices for the Ordinary Shares, the Issuer's financial position, operations, assets, prospects, strategic direction and business and other developments affecting the Issuer. The Reporting Person may from time to time take such a… Full filing |
30.7% |
Mellon James
13D · may seek influence
+2.9 pts · filed 2025-01-31
Stated purposeThe reporting person acquired 121,951 ordinary shares, in an exempt private offering, at $4.10 per share, by agreement dated January 23, 2025, as an investment, to provide operating capital to the issuer, Portage Biotech Inc. The securities currently held and that were acquired as reported herein, are being held for investment purposes. The Reporting Person intends to review his investment in the Issuer on a continuing basis and will routinely monitor a wide variety of investment considerations, including, without limitation, current and anticipated future trading prices for the Ordinary Shares, the Issuer's financial position, operations, assets, prospects, strategic direction and business and other developments affecting the Issuer. The Reporting Person may from time to time take such a… Full filing |
16.7% |
| JANE STREET GROUP, LLC 13G · passive investor new · filed 2026-06-16 | 5.6% |
| Kendall Brazos Duncan 13G · passive investor new · filed 2026-07-10 | 5.3% |
Fell to 5% or below in the last year: Orca Capital AG (4.5%, 2026-02-03)
Insider purchases and sales in Q1 2026
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported in Q1 2026.
Holders, Q1 2026
| Manager | Shares | Change |
|---|---|---|
| SABBY MANAGEMENT, LLC 11.46% of their portfolio | 2.1m $654.8k | New |
| Shay Capital LLC 0.03% of their portfolio | 612.3k $193.5k | New |
| FNY Investment Advisers, LLC 0.02% of their portfolio | 178.7k $56.0k | New |
| One68 Global Capital, LLC 0.11% of their portfolio | 112.0k $35.4k | New |
| PRELUDE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 85.0k $26.9k | New |
| Warberg Asset Management LLC 0.00% of their portfolio | 42.1k $13.6k | New |
| XTX Topco Ltd 0.00% of their portfolio | 23.2k $7.3k | New |
| TWO SIGMA SECURITIES, LLC 0.00% of their portfolio | 21.3k $6.7k | New |
| QTR Family Wealth, LLC 0.00% of their portfolio | 19.3k $6.4k | Unchanged |
| NORDEN GROUP LLC 0.00% of their portfolio | 12.5k $4.0k | New |
| JANE STREET GROUP, LLC 0.00% of their portfolio | 11.4k $3.6k | Added +1.2k |
| UBS Group AG 0.00% of their portfolio | 5.5k $1.8k | Added +5.4k |
| BlackRock, Inc. 0.00% of their portfolio | 408 $129 | Unchanged |
| JONES FINANCIAL COMPANIES LLLP 0.00% of their portfolio | 300 $89 | Unchanged |
| MORGAN STANLEY 0.00% of their portfolio | 100 $32 | Unchanged |
| ROYAL BANK OF CANADA 0.00% of their portfolio | 75 $0 | Unchanged |
| NATIONAL BANK OF CANADA /FI/ 0.00% of their portfolio | 73 $24 | Unchanged |
| BNP PARIBAS FINANCIAL MARKETS 0.00% of their portfolio | 9 $3 | Unchanged |
| Princeton Global Asset Management LLC 0.00% of their portfolio | 8 $3 | Unchanged |
| OSAIC HOLDINGS, INC. 0.00% of their portfolio | 5 $1 | Reduced -50 |
| CITIGROUP INC 0.00% of their portfolio | 1 $0 | New |
| Federation des caisses Desjardins du Quebec 0.00% of their portfolio | 1 $0 | Unchanged |